/PRNewswire/ CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company"), announces a correction to its press release entitled "CBAK.
Jack Dorsey s Square to Acquire Jay-Z s Tidal Streaming Service for $297 Million
Todd Spangler, provided by
FacebookTwitterEmail
Square, the payments-processing company led by CEO Jack Dorsey, announced plans to buy a “significant” majority stake in Tidal, the music and entertainment streaming platform run by Jay-Z.
Square said it expects to pay a $297 million, in a combination of cash and stock, for the Tidal stake, with existing artist shareholders the remaining stakeholders. Tidal will operate independently within Square. Shawn “Jay-Z” Carter is expected to join Square’s board, subject to the closing of the transaction.
More from Variety
Why is Square buying Tidal? The company sees an opportunity in enabling direct-to-fan business models. According to Square, the deal will extend its “purpose of economic empowerment” to musicians a new category for the payments company. Square plans to bring new systems and tools to help artists find new ways to support thei
4.2.3 Wellness Hurts
4.3 Instrumentation and Automation
4.3.2 The Shrinking Machine.
4.4 Diagnostic Technology Development
4.4.2 POCT/Self Testing as a Disruptive Force
4.4.3 The Genetics Play - One Test for All Known Infections
4.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics
5. Molecular Dx - Infectious Disease Recent Developments
Recent Developments- Importance and How to Use This Section
Importance of These Developments
Fusion Genomics to Assess NGS-Based Respiratory Tract Infection Assay
New Genomic Tests Diagnose Deadly Infections Faster
Biotia Raises $2.4M Seed Round
STDs resurge in US
Cell-Free DNA Used for Infectious Disease Testing
One BioMed Raises $5M
iCubate, Wondfo Biotech Form Chinese JV to Develop MDx Assays
Global Infectious Disease Molecular Diagnostics Markets Report 2021 - Multiplex Testing Threatens Existing Assays / Test Speed Taking Centre Stage.
February 02, 2021 04:38 ET | Source: Research and Markets Research and Markets Dublin, IRELAND
Multiplex testing threatens existing infectious disease practice. The microbiology lab may disappear.
The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for record growth.
A market that just keeps on growing. In spite of the steady decline of disease prevalence, the diagnostic sector keeps growing. Find out why in the informative report. And find out about the exciting developments in multiplex assays which threaten to change diagnosis and treatment while limiting the threat of anti microbial drug resistance.
Global Molecular Diagnostics for Infectious Disease Markets Report 2021: COVID-19 Drives a Surge in Demand - Microbiology Lab my Disappear while Multiplex Takes Center Stage yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.